Glaucoma Aqueous Shunt Device Market Size, Share, Growth, and Industry Analysis, By Type (valved drainage implant, non valved drainage implant & Others), By Application (Hospitals, ophthalmology clinics, ambulance service center & Others), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

GLAUCOMA AQUEOUS SHUNT MARKET REPORT OVERVIEW

Global glaucoma aqueous shunt device market size was estimated at usd 0.61 billion in 2024, set to expand to usd 1.34 billion by 2033, growing at a CAGR of 6.5% during the forecast period.

The global glaucoma aquueous shunt device market is also poised for substantial growth in the coming years, driven by several factors. The increasing focus on surgical technologies and presence of growing glaucoma disease in people. This market is continuously growing as many new companies are also investing in the device market. Hospitals hold the largest market share because they need advanced surgical equipment. 

Moreover, advancements in design and manufacturing technologies are driving innovations in the glaucoma aqueous shunt device. Manufacturers are investing in research and development to introduce modern and aesthetically pleasing shunt device designs, catering to diverse consumer preferences. Technological advancements, such as improved components options and assembly methods, enable more functional and durable device creations. The combination of evolving consumer preferences and technological advancements is fueling the expansion of the global market.

COVID-19 IMPACT

Market Growth Restrained by Pandemic due to Supply Chain Disruptions

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The pandemic resulted in disruptions to supply chains, manufacturing operations, and retail businesses, leading to reduced consumer spending and demand for non-covid related items like glaucoma shunt devices. Lockdowns and social distancing measures also limited workforce shortage further affecting sales and distribution channels. As a result, the glaucoma shunt device market experienced a decline in demand and revenue during the pandemic. While the market may eventually recover as the situation improves, the immediate impact of COVID-19 was predominantly negative for the global market.

LATEST TRENDS

Smart Features in glaucoma  aqueous shunt devices to Drive Market Growth

The latest trend in the glaucoma aqueous shunt device market is the advancement in technology and increase in adoption of new devices among people. Companies are developing advanced technology in which these devices are connected through their mobile phones which can tell each and every detail about the device. Infact, consumers can monitor their device and know whether it's working properly or not. Because of the self monitor technique patients have to have shorter hospital stays.

Request a Free sample to learn more about this report

GLAUCOMA AQUEOUS SHUNT DEVICE  MARKET SEGMENTATION

By Type

• Valved Drainage Implants: The valve mechanism in these implants helps to predict and control reduction in intraocular pressure. They are designed in the way that it can reduce the flow of aqueous humor from inside of the eyes to outside.They reduce the risk of hypotony because of which the operation is successful. They give the solution for the glaucoma for the long term, Non-valved Drainage Implants. They are useful in the case where valved drainage implants are not suitable. They do not have built in technology on valve mechanisms to control IOP. There are different methods to control IOP in non valved drainage implants. They allow the drainage of aqueous humor to flow from inside of the eye to outside of the eye.

By Application

• Hospital: Hospitals have the largest market share for the glaucoma shunt devices as in the global glaucoma shunt device market. Hospitals have advanced surgical technology to use the device carefully and fit in properly in the eyes of the patients. Hospitals offer good care for their patients during and after the surgery. They have the capability to manage the patients with high risk.

• Ophthalmology Clinics: These clinics often handle the patients who are in their early stage of the glaucoma disease. Patients who are not at high risk for the disease can be treated in the clinics only. Clinics are more convenient for the patients as it prevents to

• Ambulatory Surgery : Centers Visit hospitals and stay for longer duration. Ambulatory surgery centers are increasingly being used by patients as they are efficient and cost effective. They often cost less for the procedure as compared to the hospitals and clinics. Some of these ambulances are tailored for special surgeries only including glaucoma shunt technology.

DRIVING FACTORS

Increasing in prevalence of glaucoma patients to Boost the Market

One of the key driving factors in the global glaucoma aqueous shunt device market growth is the increasing urbanization and old age population. As Global population of old age people increases, the number of glaucoma patients increases. Moreover, patients require a good glaucoma shunt device for themselves so that they can stop the spread of the disease. Nowadays, increase in many more health problems like diabetes, blood pressure also affect the eyes people can develop many type of eye disease.

Increase in Hospitals and ophthalmology clinics to Expand the Market

Another driving factor in the glaucoma aqueous shunt device market is the increase in the number of Hospitals and ophthalmology clinics all over the world. Ophthalmology clinics are often more budget-friendly compared to going to hospitals. This cost-effectiveness appeals to a wide range of patients, including students, old age people and budget-conscious individuals. Hospitals have the largest market share for the glaucoma shunt device market. They can deal the patient with high risks of the disease

RESTRAINING FACTORS

High cost and alternative treatment Impede Market Growth

One of the key restraining factors in the global glaucoma aqueous shunt device market is the high cost associated with the devices. To install the device in a patient requires an implantation process which is also high in cost apart from the device. This could hinder the market's growth to some extent. Moreover, there are many alternative options there apart from installing the devices like laser therapies, medications and others that are suggested by doctors because of the high cost of these devices. However, many technologies are being explored to bring down the cost of these devices  to address this restraining factor.

• Request a Free sample to learn more about this report

•  

GLAUCOMA AQUEOUS  SHUNT DEVICE MARKET REGIONAL INSIGHTS

North America Dominating The Market Due Advanced Healthcare System

The market is primarily segregated into Europe, United states, Canada, China, Japan and India

The United States has emerged as the most dominant region in the global glaucoma aqueous shunt device market share due to several factors. The region's dominance is attributed to its advanced healthcare systems and rapid urbanization, leading to a significant demand for advanced medical technologies. solutions. The United States spends a huge amount of their fund in the healthcare system that drives the market growth. Many companies that just make the ophthalmic devices are present there. There are many good insurance policies that give assurance for the reimbursement and also help in expansion of glaucoma shunt devices.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

The glaucoma aqueous shunt device market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of shunt device options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features in cloth wardrobes, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.

List of Top Glaucoma Aqueous Shunt Device Companies

1. AbbVie (U.S.)
2. Santen Pharmaceutical (Japan)
3. Johnson and Johnson (U.S.)
4. Advanced Ophthalmic Innovations (AOI) (U.S.)
5. New World Medical (U.S.)
6. Glaukos Corp (Japan)
7. Ocular Therapeutix (U.S.)
8. PolyActiva (Australia)

INDUSTRIAL DEVELOPMENT

January, 2022: Many companies like Abbvie, Santen pharmaceutical have launched XEN Gel stent to lower high pressure in glaucoma patients. Previous shunt devices were not sufficient alone in providing medication but these XEN Gel devices are all in one solution.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated time frame. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.